Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits

Circulation Research

Volumn 85, Issue 6, 1999, Pages 542-550

  Ping, Peipei ^a,b,c   Zhang, Jun ^a,b   Zheng, Yu Ting ^b   Li, Richard C X ^a,b   Dawn, Buddhabeb ^a   Tang, Xian Liang ^a   Takano, Hitoshi ^a   Balafanova, Zarema ^a,b   Bolli, Roberto ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Cardiac signaling; Chelerythrine; Lavendustin A; Myocardial infarction; Myocardial stunning; PKC

Indexed keywords

CHELERYTHRINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; LAVENDUSTIN A; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; STUNNED HEART MUSCLE;

EID: 0033578895     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.6.542     Document Type: Article

References (64)

1. Baines CP, Wang L, Cohen MV, Downey JM. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol. 1998;30:383-392.
2. Baxter GF, Goma FM, Yellon DM. Characterization of the infarct limiting effect of delayed preconditioning: time course and dose-dependency studies in rabbit myocardium. Basic Res Cardiol. 1997;92: 159-167.
3. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol. 1998;93:325-338.
4. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Zhang Q, Guo Y, Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as mediator of the late phase of preconditioning. Circ Res. 1997;81:1094-1107.
5. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42-52.
6. Cohen MV, Downey JM. Preconditioning during ischemia: basic mechanism and potential clinical applications. Cardiol Rev. 1995;3: 137-149.
7. Imagawa J, Baxter GF, Yellon DM. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. J Mol Cell Cardiol. 1997;29:1885-1893.
8. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 1993;72:1293-1299.
9. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol. 1994;26:661-668.
10. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88: 1264-1272.
11. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 1996;396:233-237.
12. Maulik N, Yoshida T, Zu YL, Sato M, Banerjee A, Das DK. Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol. 1998;275:1857-1864.
13. Qiu Y, Rizvi A, Tang XL, Machikalapudi S, Takano H, Jadoon AK, Wu WJ, Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol. 1997;273:2931-2936.
14. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 1998;98:441-449.
15. Weinbrenner C, Liu GS, Cohen MY, Downey JM. Phosphorylation of tyrosine 182 of p38 MAPK correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol. 1997;29:2383-2391.
16. Xuan YT, Tang XL, Banerjee S, Takano H, Li RCX, Han H, Qiu Y, Li J, Bolli R. Nuclear factor κB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res. 1999;84: 1095-1099.
17. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266: H1145-H1152.
18. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol. 1995;115:222-224.
19. Gray, MO, Karliner JS, Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem. 1997;272:30945-30951.
20. Mitchell MB, Meng X, Ao L, Brown JM, Harken AK, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995;76:73-81.
21. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RCX, Banerjee S, Dawn B, Balafonova Z, Bolli R. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res. 1999;84:587-604.
22. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R. Ischemic preconditioning induces selective translocation of PKC isoforms ∈ and η in the heart of conscious rabbits without subcellular redistribution of total PKC activity. Circ Res. 1997;81:404-414.
23. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu WJ, Teschner S, Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that ∈ is the isoform involved. J Clin Invest. 1998;101:2182-2198.
24. Strasser RH, Braun-Dullaeus R, Walendzik H, Marquetant R. α1-receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanisms for sensitization of the adenylyl cyclase system. Circ Res. 1992;70:1304-1312.
25. Maulik N, Sato M, Price BD, Das DK. An essential role of NF-κB in tyrosine kinase signaling of p38 MAPK regulation of myocardial adaptation to ischemia. FEBS Lett. 1998;429:365-369.
26. Neet K, Hunter T. Vertebrate non-receptor protein-tyrosine kinase families. Genes Cells. 1996;1:147-169.
27. Van der Geer P, Hunter T, Lindberg RA. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol. 1994;10:251-337.
28. cas in differentiating neuroblastoma cells. J Biol Chem. 1998;273:2336-2343.
29. Levi NL, Hanoch T, Benard O, Rozenblat M, Harris D, Reiss N, Naor Z, Seger R. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary αT3-1 cell line is mediated by protein kinase C, c-Src, and CDC 42. Mol Endocrinol. 1998;12:815-824.
30. Offermanns S, Bombien E, Schultz G. Stimulation of tyrosine phosphorylation and MAPK activity in human SH-SY5Y neuroblastoma cells by carbachol. Biochem J. 1993;294:545-550.
31. Seger R, Biener Y, Feinstein R, Hanoch T, Gazit A, Zick Y. Differential activation of MAPK and S6 kinase signaling pathways by TPA and insulin: evidence for involvement of a TPA-stimulated protein-tyrosine kinase. J Biol Chem. 1995;270:28325-28330.
32. Superti-Furga G. Regulation of the Src protein tyrosine kinase. FEBS Lett. 1995;369:62-66.
33. Superti-Furga G, Courtneidge SA. Structure-function relationships in Src family and related protein tyrosine kinases. Bioessays. 1995;17:321-330.
34. Dawn B, Qiu Y, Tang XL, Takano H, Banerjee S, Bolli R. Involvement of tyrosine kinases in the development of late preconditioning against myocardial stunning in conscious rabbits. J Mol Cell Cardiol. 1998; 30:A264. Abstract.
35. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987;262:5592-5595.
36. O'Dell TJ, Kandel ER, Grant SG. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature. 1991;353: 558-560.
37. Onoda T, Iinuma H, Sasaki Y, Hamada M, Isshiki K, Naganawa H, Takeuchi T, Tatsuta K, Umezawa K. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. J Nat Prod. 1989;52:1252-1257.
38. Hsu CJ, Persons PE, Spada AP, Bednar RA, Levitzki A, Zilberstein A. Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by lavendustin-A and its analogue. J Biol Chem. 1991; 266:21105-21112.
39. Brown, MT, Cooper JA. Regulation, substrates and functions of Src. Biochim Biophys Acta. 1996;1287:121-149.
40. Corey SJ, Anderson SM. Src-related protein tyrosine kinases in hematopoiesis. Blood. 1999;93:1-14.
41. Williams JC, Wierenga RK, Saraste M. Insights into Src kinase functions: structural comparisons. Trends Biochem Sci. 1998;23:179-184.
42. Schwartz LM, Jennings RB, Reimer KA. Premedication with opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs. Basic Res Cardiol. 1997;92:106-114.
43. Triana JF, Li X-Y, Jamaluddin U, Thornby JI, Bolli R. Postischemic myocardial "stunning": identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res. 1991;69:731-747.
44. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM. Anesthetics alter the magnitude of infarct limitation by ischemic preconditioning. Cardiovasc Res. 1994;28:1574-1580.
45. Li X-Y, McCay PB, Zughaib M, Jeroudi MO, Triana JF, Bolli R. Demonstration of free radical generation in the "stunned" mycardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest. 1993;92:1025-1041.
46. Ping P, Zhang J, Cao X, Li RCX, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach J, Black RG, Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia/reperfusion in conscious rabbits. Am J Physiol. 1999;276:1468-1481.
47. Ping P, Zhang J, Huang S, Cao X, Tang XL, Li RCX, Zheng YT, Qiu Y, Clerk A, Sugden P, Han JH, Bolli R. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. Am J Physiol. In press.
48. Sudol, M, Greulich H, Newman L, Sarkar A, Sukegawa J, Yamamoto T. A novel Yes-related kinase, Yrk, is expressed at elevated levels in neural and hematopoietic tissues. Oncogene. 1993;8:823-831.
49. Cheng HC, Nishio H, Hatase O, Ralph S, Wang JH. A synthetic peptide derived from p34 cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J Biol Chem. 1992;267:9248-9256.
50. Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Nerendran A, Timms E, Wakeham A, Paige CJ, Hartmann KU, Veilette A, Davidson D, Mak TW. Profound block in thymocyte development in mice laking p56 lck. Nature. 1992;357:161-164.
51. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
52. Zou Y, Komuro I, Yamazaki T, Kudoh S, Aikawa R, Zhu W, Shiojima I, Hiroi Y, Tobe K, Kadowaki T, Yazaki Y. Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gβγ subunits, Src family, and Ras in cardiac fibroblasts. Circ Res. 1998;82:337-345.
53. Puceat M, Roche S, Vassort G. Src family tyrosine kinase regulates intracellular pH in cardiomyocytes. J Cell Biol. 1998;141:1637-1646.
54. Nagao M, Yamauchi J, Kaziro Y, Itoh H. Involvement of protein kinase C and Src family tyrosine kinase in Gαq/11-induced activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J Biol Chem. 1998;273:22892-22898.
55. Gniadecki R. Nongenomic signaling by vitamin D: a new face of Src. Biochem Pharmacol. 1997;56:1273-1277.
56. Khare S, Bolt MJ, Wali RK, Skarosi SF, Roy HK, Niedziela S, Scaglione-Sewell B, Aquino B, Abraham C, Sitrin MD, Brasitus TA, Bissonnette M. 1,25-Dihydroxyvitamin D3 stimulates phospholipase C-gamma in rat colonocytes: role of c-Src in PLC-gamma activation. J Clin Invest. 1997; 99:1831-1841.
57. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993-999.
58. Li S, Ke S, Budde RJA. The C-terminal SRC kinases (Csk) is widely expressed, active in HT-29 cells that contain activated SRC, and its expression is downregulated in butyrate-treated SW620 cells. Cell Biol Int. 1999;20:723-729.
59. Fryer RM, Schultz JE, Hsu AK, Gross GJ. Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in rat hearts. Am J Physiol. 1998;275:2009-2015.
60. Fryer RM, Schultz JE, Hsu AK Gross GJ. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol. 1999;276:1229-1235.
61. Vahlhaus C, Schulz R, Post H, Rose J, Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol. 1998;30:197-209.
62. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation. 1995;92:1546-1557.
63. Vahlhaus C, Schulz, R, Post H, Onallah R, Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor straurosporine in swine. Circ Res 1996;79:407-414.
64. Vogt A, Barancik M, Weihrauch D, Arras M, Podzuweit T, Schaper W. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo. Circulation. 1994;90:I-647. Abstract.